Details of ADC Therapeutics' oral presentation at AACR are as follows: Title: Preclinical investigation of ADCT-242, a novel exatecan-based antibody drug conjugate targeting Claudin-6, as single ...
All titles, abstracts, photos and YouTube presentations will need your research mentor’s approval prior to submitting your abstract. The abstract will be open to public viewing. Submit your abstract ...
Presenters must provide the name, institution and email of the non-CWRU mentor (and PI if different) with whom they worked. The project mentor (or PI if different) must approve the research ...
BioAtla has two abstracts accepted for poster presentations at major oncology conferences, enhancing visibility in the scientific community. The presentations will feature cutting-edge research on ...
today announced the acceptance of seventeen abstracts for presentation at the AACR Annual Meeting, in Chicago, IL (April 25-30, 2025). These presentations will highlight Champions' cutting-edge ...